MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 90 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $21,074,500 | -24.9% | 2,331,250 | -9.7% | 0.04% | -31.0% |
| Q4 2023 | $28,058,188 | +20.0% | 2,581,250 | -11.1% | 0.06% | +9.4% |
| Q3 2023 | $23,381,032 | -21.2% | 2,904,476 | +6.3% | 0.05% | -17.2% |
| Q2 2023 | $29,661,375 | +111.3% | 2,731,250 | +34.2% | 0.06% | +106.5% |
| Q1 2023 | $14,038,050 | +71.8% | 2,034,500 | -0.9% | 0.03% | +55.0% |
| Q4 2022 | $8,168,950 | -0.7% | 2,052,500 | +65.9% | 0.02% | 0.0% |
| Q3 2022 | $8,229,000 | +34.7% | 1,237,500 | -2.0% | 0.02% | +42.9% |
| Q2 2022 | $6,111,000 | -48.2% | 1,262,500 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $11,804,000 | -21.3% | 1,262,500 | 0.0% | 0.02% | -18.5% |
| Q4 2021 | $14,999,000 | +4.4% | 1,262,500 | 0.0% | 0.03% | -3.6% |
| Q3 2021 | $14,367,000 | -36.6% | 1,262,500 | 0.0% | 0.03% | -36.4% |
| Q2 2021 | $22,649,000 | +0.0% | 1,262,500 | -13.7% | 0.04% | -4.3% |
| Q1 2021 | $22,640,000 | +26.9% | 1,462,500 | 0.0% | 0.05% | +17.9% |
| Q4 2020 | $17,843,000 | -5.1% | 1,462,500 | 0.0% | 0.04% | -17.0% |
| Q3 2020 | $18,793,000 | – | 1,462,500 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,156,803 | $15,279,000 | 3.01% |
| Lion Point Capital, LP | 3,684,622 | $18,959,000 | 2.16% |
| Bleichroeder LP | 1,322,463 | $6,401,000 | 1.32% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $6,926,000 | 0.81% |
| 683 Capital Management, LLC | 1,900,000 | $9,196,000 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,510,831 | $16,992,000 | 0.65% |
| Granite Point Capital Management, L.P. | 472,056 | $2,285,000 | 0.58% |
| Stonepine Capital Management, LLC | 242,327 | $1,173,000 | 0.55% |
| Avoro Capital Advisors LLC | 3,150,000 | $15,246,000 | 0.30% |
| Artal Group S.A. | 1,000,000 | $4,840,000 | 0.26% |